MFS
AERI

MSI Financial Services’s Aerie Pharmaceuticals AERI Stock Holding History

MSI Financial Services’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$19K Hold
501
– – ﹤0.01% 2441
2016
Q3 		$19K Hold
501
– – ﹤0.01% 2423
2016
Q2 		$9K Sell
501
-62
-11% -$1K ﹤0.01% 2850
2016
Q1 		$7K Buy
563
+493
+704% +$7.8K ﹤0.01% 3008
2015
Q4 		$2K Buy
70
+3
+4% +$70 ﹤0.01% 3510
2015
Q3 		$1K Buy
+67
New +$1.21K ﹤0.01% 3043

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSI Financial Services's AERI Position: Q4 2016 in Review

MSI Financial Services held its Aerie Pharmaceuticals (AERI) position steady in Q4 2016 at 501 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

MSI Financial Services first reported a position in AERI in Q3 2015 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • MSI Financial Services held 501 shares of Aerie Pharmaceuticals worth $19K as of Q4 2016.
  • MSI Financial Services left its Aerie Pharmaceuticals share count unchanged in Q4 2016.
  • Aerie Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2441 holding.
  • MSI Financial Services first reported a position in Aerie Pharmaceuticals in Q3 2015 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.